X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (71) 71
nitric oxide (56) 56
humans (54) 54
animals (53) 53
guanylate cyclase - metabolism (37) 37
soluble guanylyl cyclase (37) 37
male (36) 36
nitric oxide - metabolism (36) 36
nitric-oxide (34) 34
sgc (34) 34
cgmp (33) 33
cyclic gmp - metabolism (30) 30
pharmacology & pharmacy (29) 29
biochemistry & molecular biology (27) 27
soluble guanylate cyclase (26) 26
receptors, cytoplasmic and nuclear - metabolism (24) 24
rats (20) 20
activation (19) 19
benzoates - pharmacology (17) 17
cyclic gmp (17) 17
guanylate cyclase (16) 16
pyrazoles - pharmacology (16) 16
soluble guanylate-cyclase (16) 16
nitric-oxide synthase (15) 15
sgc activator (15) 15
female (14) 14
heme (14) 14
oxidative stress (14) 14
cardiovascular system (13) 13
cell biology (13) 13
cyclic-gmp (13) 13
expression (13) 13
mice (13) 13
heart failure (12) 12
hypertension (12) 12
pulmonary hypertension (12) 12
pyridines - pharmacology (12) 12
sgc activators (12) 12
sgc stimulator (12) 12
signal transduction (12) 12
soluble guanylyl cyclase - metabolism (12) 12
enzyme activators - pharmacology (11) 11
stimulators (11) 11
analysis (10) 10
cinaciguat (10) 10
rats, wistar (10) 10
riociguat (10) 10
yc-1 (10) 10
article (9) 9
cyclic guanylic acid (9) 9
erectile dysfunction (9) 9
health aspects (9) 9
proteins (9) 9
apoptosis (8) 8
bay 58-2667 (8) 8
biphenyl compounds - pharmacology (8) 8
cardiac & cardiovascular systems (8) 8
cells, cultured (8) 8
dependent protein-kinase (8) 8
enzyme inhibitors - pharmacology (8) 8
guanylate cyclase - antagonists & inhibitors (8) 8
guanylate cyclase - chemistry (8) 8
hydrocarbons, fluorinated - pharmacology (8) 8
hypertension, pulmonary - drug therapy (8) 8
independent activation (8) 8
inhibition (8) 8
neurosciences (8) 8
nitric oxide donors - pharmacology (8) 8
nitroprusside - pharmacology (8) 8
physiology (8) 8
sgc stimulators (8) 8
signal transduction - drug effects (8) 8
bay 41-2272 (7) 7
dose-response relationship, drug (7) 7
endothelial dysfunction (7) 7
enzyme activation (7) 7
enzymes (7) 7
guanosine (7) 7
guanylyl cyclase (7) 7
in vitro techniques (7) 7
inorganic chemicals (7) 7
no, nitric oxide (7) 7
biophysics (6) 6
blood-pressure (6) 6
care and treatment (6) 6
crystal-structure (6) 6
cyclic guanosine monophosphate (6) 6
drugs (6) 6
fibrosis (6) 6
heart-failure (6) 6
pharmacology (6) 6
physiological aspects (6) 6
pulmonary-hypertension (6) 6
pyrimidines - pharmacology (6) 6
relaxation (6) 6
research (6) 6
signal transduction - physiology (6) 6
smooth-muscle-cells (6) 6
solubility (6) 6
arterial-hypertension (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biochemical Pharmacology, ISSN 0006-2952, 01/2018, Volume 147, pp. 10 - 20
[Display omitted] Nitric oxide sensitive guanylyl cyclase (NOsGC), a hemoprotein and the major physiological receptor for nitric oxide (NO), is a heterodimer... 
Enzyme isoforms | sGC activator | Guanylyl cyclase | Cyclic GMP | Nitric oxide | ALPHA SUBUNIT | NO | SITE | PROTEIN | PULMONARY ARTERIAL-HYPERTENSION | HEART-FAILURE | S-NITROSYLATION | PHARMACOLOGY & PHARMACY | INDEPENDENT ACTIVATION | STIMULATORS | HEME-BINDING | Drugs | Enzymes | Protein biosynthesis | Analysis | Heme | Index Medicus
Journal Article
Experimental Cell Research, ISSN 0014-4827, 11/2015, Volume 338, Issue 2, pp. 162 - 169
Fibrotic diseases encompass numerous systemic and organ-specific disorders characterized by the development and persistence of myofibroblasts. TGFβ1 is... 
sGC activation | NO/cGMP signaling | sGC stimulation | PDE5 inhibition | Myofibroblast | Fibrosis | SGC activation | SGC stimulation | SURVIVAL | FIBROBLAST | TISSUE | CELL BIOLOGY | TRANS-DIFFERENTIATION | INHIBITION | ONCOLOGY | BENIGN | DISEASE | EXPRESSION | MOLECULAR-MECHANISMS | Humans | Actins - metabolism | Hydrocarbons, Fluorinated - pharmacology | Male | Fibrosis - metabolism | Prostate - metabolism | Myofibroblasts - metabolism | Biphenyl Compounds - pharmacology | Insulin-Like Growth Factor Binding Protein 3 - metabolism | Stromal Cells - drug effects | Prostate - drug effects | Myocytes, Smooth Muscle - drug effects | Cell Differentiation - physiology | Myocytes, Smooth Muscle - metabolism | Extracellular Matrix Proteins - metabolism | Pyrazoles - pharmacology | Stromal Cells - metabolism | Cells, Cultured | Guanylate Cyclase - metabolism | Soluble Guanylyl Cyclase | Myofibroblasts - drug effects | Cyclic GMP - metabolism | Signal Transduction - drug effects | Cell Differentiation - drug effects | Benzoates - pharmacology | Signal Transduction - physiology | Pyridines - pharmacology | Nitric Oxide - metabolism | Transforming Growth Factor beta - metabolism | Receptors, Cytoplasmic and Nuclear - metabolism | Surgery, Plastic | Transforming growth factors | Health aspects | Nitric oxide | Digital integrated circuits | Fibroblasts | Prostate cancer | Cells
Journal Article
Journal Article
Journal Article
American Journal of Physiology - Lung Cellular and Molecular Physiology, ISSN 1040-0605, 11/2011, Volume 301, Issue 5, pp. L755 - L765
Chester M, Seedorf G, Tourneux P, Gien J, Tseng N, Grover T, Wright J, Stasch J, Abman SH. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP... 
Bay 58-2667 | Pulmonary hypertension therapy | SGC stimulators | Persistent pulmonary hypertension of the newborn | Cyclic GMP | Nitric oxide | NADPH OXIDASE | nitric oxide | SUPEROXIDE | PHYSIOLOGY | CIRCULATION | NITRIC-OXIDE SYNTHASE | cyclic GMP | RELAXING FACTOR | persistent pulmonary hypertension of the newborn | NEWBORN-INFANT | OVINE FETUS | RESPIRATORY SYSTEM | pulmonary hypertension therapy | SMOOTH-MUSCLE-CELLS | EXPRESSION | FETAL LAMBS | Hydrogen Peroxide - adverse effects | Quinoxalines - adverse effects | Humans | Nitroprusside - pharmacology | Pulmonary Artery - metabolism | Isoenzymes - metabolism | Vascular Resistance - drug effects | Female | Fetus | Myocytes, Smooth Muscle - drug effects | Cyclic GMP - biosynthesis | Myocytes, Smooth Muscle - cytology | Myocytes, Smooth Muscle - metabolism | Infant, Newborn | Persistent Fetal Circulation Syndrome - physiopathology | Disease Models, Animal | Vasodilator Agents - pharmacology | Cells, Cultured | Cyclic GMP - analysis | Guanylate Cyclase - metabolism | Soluble Guanylyl Cyclase | Pulmonary Artery - physiopathology | Receptors, Cytoplasmic and Nuclear - agonists | Persistent Fetal Circulation Syndrome - metabolism | Persistent Fetal Circulation Syndrome - drug therapy | Pregnancy | Oxadiazoles - adverse effects | Animals | Benzoates - pharmacology | Sheep | Pulmonary Circulation - drug effects | Vasodilation - drug effects | Nitric Oxide - metabolism | Persistent Fetal Circulation Syndrome - pathology | Pulmonary Artery - pathology | Receptors, Cytoplasmic and Nuclear - metabolism | Complications and side effects | Dilatation | Physiological aspects | Blood vessels | Genetic aspects | Research | Cyclic guanylic acid | Pulmonary hypertension
Journal Article
Journal Article
Methods in Molecular Biology, ISSN 1064-3745, 2013, Volume 1020, pp. 205 - 214
Conference Proceeding
European Journal of Pharmacology, ISSN 0014-2999, 05/2020, p. 173203
Journal Article
Journal Article